TFAP4 (transcription factor AP-4) is a sequence-specific DNA-binding transcription factor that regulates gene expression by binding to symmetrical DNA sequences, particularly E-box motifs 1. The protein functions as both a transcriptional activator and repressor depending on cellular context. TFAP4 plays critical roles in cancer progression across multiple tumor types, where it is frequently upregulated in malignant epithelial cells and associated with poor patient survival 2. Mechanistically, TFAP4 promotes oncogenesis through multiple pathways: it activates IGF2BP1 to stabilize TK1 expression via m6A modification in lung cancer 3, regulates MCM5 to activate PI3K/AKT signaling in gastric cancer 4, and controls mechanotransduction by directly activating mechanosensors like Itga11 and Piezo2 in cardiac fibrosis 5. In T-cell malignancies, TFAP4 serves as a key regulator of Galectin-9 expression 6. The transcription factor also influences therapeutic responses, as TFAP4 knockdown enhances chemotherapy efficacy and is downregulated following anti-PD-1 treatment 2. Paradoxically, TFAP4 can enhance CAR-T cell fitness under chr16 stimulation conditions 7. These diverse functions establish TFAP4 as both a prognostic biomarker and potential therapeutic target across multiple diseases.